“Colistin as A Good Monotherapy to Restrain the Pathogenicity of Acinetobacter baumannii In vivo and In vitro”, Baghdad Sci.J, vol. 19, no. 2, p. 0255, Apr. 2022, doi: 10.21123/bsj.2022.19.2.0255.